These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22330860)

  • 1. Variability in the response to antiplatelet treatment in diabetes mellitus.
    Davì G; Vazzana N; Sestili S
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):48-55. PubMed ID: 22330860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy in type 2 diabetes mellitus.
    Angiolillo DJ
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis.
    Morel O; Kessler L; Ohlmann P; Bareiss P
    Atherosclerosis; 2010 Oct; 212(2):367-76. PubMed ID: 20394927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H; Roukoz B; Surabhi SK; Cohen M
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of antiplatelet therapy in cardiovascular disease.
    Patrono C; Rocca B
    Annu Rev Med; 2010; 61():49-61. PubMed ID: 20059331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet aggregation inhibitors in diabetes mellitus].
    Abrahamian H
    Acta Med Austriaca; 1999; 26(5):137-41. PubMed ID: 11512189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.
    Bulatova NR; Yousef AM; AbuRuz SM
    Thromb Res; 2007; 121(1):43-50. PubMed ID: 17462716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
    Santilli F; Lapenna D; La Barba S; Davì G
    Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming aspirin treatment failure in diabetes.
    Linden MD; Tran HA
    Crit Rev Clin Lab Sci; 2012; 49(5-6):183-98. PubMed ID: 23094974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy: controversial aspects.
    Coccheri S
    Thromb Res; 2012 Mar; 129(3):225-9. PubMed ID: 22119155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus.
    Angiolillo DJ; Suryadevara S
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):375-88. PubMed ID: 19520310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.
    Bruno A; Grassi G; Dani F; Degiovanni M; Maghenzani G; Pagano G
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):42-6. PubMed ID: 15871850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P; Jezovnik MK
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A; Violi F
    Vasc Health Risk Manag; 2007; 3(1):93-8. PubMed ID: 17583179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.
    Angiolillo DJ; Roffi M; Fernandez-Ortiz A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):697-710. PubMed ID: 21714601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
    Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J
    Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.